
OPKO Health OPK
$ 1.15
-0.86%
Quarterly report 2025-Q2
added 07-31-2025
OPKO Health P/E Ratio 2011-2026 | OPK
Annual P/E Ratio OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 86.6 | -11.2 | -2.5 | -67.3 | 113 | -2.8 | -13.8 | -8.31 | -170 | -134 | -29.6 | -25.3 | -65.9 | -1.14 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 113 | -1.14 K | -105 |
P/E Ratio of other stocks in the Diagnostics research industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
34.7 | $ 115.19 | 0.1 % | $ 35 B | ||
|
BioNano Genomics
BNGO
|
-0.301 | $ 1.14 | 0.44 % | $ 6.21 M | ||
|
Burning Rock Biotech Limited
BNR
|
-7.25 | $ 16.2 | 0.56 % | $ 174 M | ||
|
Aspira Women's Health
AWH
|
-1.67 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-0.54 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.172 | - | - | $ 9.42 M | ||
|
DermTech
DMTK
|
-0.421 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
-46.5 | $ 16.29 | 1.46 % | $ 868 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M | ||
|
Akumin
AKU
|
-0.479 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
-0.00221 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
-0.125 | $ 1.41 | 2.92 % | $ 1.88 M | ||
|
Exact Sciences Corporation
EXAS
|
-93.8 | - | - | $ 19.8 B | ||
|
Interpace Biosciences
IDXG
|
0.299 | $ 2.25 | -2.17 % | $ 9.95 M | ||
|
Accelerate Diagnostics
AXDX
|
-2.76 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
38.9 | $ 23.05 | -0.35 % | $ 640 M | ||
|
Global Cord Blood Corporation
CO
|
0.485 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-9.08 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.29 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-3.07 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
-53.3 | $ 175.38 | -0.17 % | $ 8.69 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
28.7 | $ 498.64 | 1.04 % | $ 14.4 B | ||
|
Danaher Corporation
DHR
|
41.4 | $ 190.7 | 0.6 % | $ 136 B | ||
|
Heska Corporation
HSKA
|
-42.4 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.138 | - | -20.0 % | $ 1.06 M | ||
|
Myriad Genetics
MYGN
|
-1.12 | $ 4.47 | 2.64 % | $ 414 M | ||
|
Illumina
ILMN
|
-13.4 | $ 122.51 | 1.3 % | $ 19.5 B | ||
|
NeoGenomics
NEO
|
-13.7 | $ 7.94 | 3.19 % | $ 1.02 B | ||
|
Fulgent Genetics
FLGT
|
-10.9 | $ 14.95 | 3.57 % | $ 452 M | ||
|
Guardant Health
GH
|
-32.3 | $ 78.76 | 0.2 % | $ 9.87 B | ||
|
QIAGEN N.V.
QGEN
|
102 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
-0.00947 | $ 2.77 | 2.97 % | $ 89.9 K | ||
|
Biomerica
BMRA
|
-1.45 | $ 2.07 | -3.19 % | $ 4.75 M | ||
|
Invitae Corporation
NVTA
|
-5.12 | - | - | $ 21.2 M | ||
|
Koninklijke Philips N.V.
PHG
|
9.27 | $ 28.27 | -0.12 % | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
21 | $ 107.75 | 0.88 % | $ 8.89 B | ||
|
Laboratory Corporation of America Holdings
LH
|
27.3 | $ 261.97 | 0.4 % | $ 21.8 B | ||
|
Natera
NTRA
|
-9.69 | $ 199.83 | 3.52 % | $ 19.7 B | ||
|
Celcuity
CELC
|
-30.3 | $ 118.95 | 1.55 % | $ 5.56 B | ||
|
Senseonics Holdings
SENS
|
-5.07 | $ 6.67 | -0.15 % | $ 278 M | ||
|
Lantheus Holdings
LNTH
|
21.9 | $ 80.99 | 0.5 % | $ 5.47 B | ||
|
Motus GI Holdings
MOTS
|
-0.0769 | - | -34.28 % | $ 263 K | ||
|
Quest Diagnostics Incorporated
DGX
|
23.5 | $ 192.07 | 0.29 % | $ 21.3 B | ||
|
Soleno Therapeutics
SLNO
|
99.7 | $ 52.58 | -0.1 % | $ 2.67 B | ||
|
Neogen Corporation
NEOG
|
-0.933 | $ 9.19 | -2.46 % | $ 1.99 B | ||
|
ENDRA Life Sciences
NDRA
|
-0.521 | $ 5.0 | 1.21 % | $ 3.94 M | ||
|
Organovo Holdings
ONVO
|
-1.25 | - | -2.3 % | $ 19.4 M |